Nuvalent (NUVL) Earnings Analysis
Nuvalent (NUVL) next reports earnings on 2026-08-06, consensus EPS -1.44 USD. Last quarter (2026-05-07) it missed with EPS -1.39 USD vs -1.35 USD est (-3%). It has beaten estimates in 1/6 recent quarters (17%). Trailing P/E -20.46.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NUVL next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -1.44 USD |
| Revenue estimate | 0.00B |
NUVL earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -1.39 USD | -1.35 USD | -3% | Miss |
| 2026-02-26 | -1.29 USD | -1.48 USD | +12.8% | Beat |
| 2025-10-30 | -1.7 USD | -1.39 USD | -22.3% | Miss |
| 2025-08-07 | -1.31 USD | -1.27 USD | -3.1% | Miss |
| 2025-02-27 | -1.05 USD | -1.04 USD | -1% | Miss |
| 2024-08-08 | -0.88 USD | -0.76 USD | -15.8% | Miss |
Beat rate: 1/6 (17%) over reported quarters with consensus data.
NUVL valuation and analyst view
| Trailing P/E | -20.46 |
|---|---|
| Trailing EPS | -5.72101 USD |
| Price / book | 8.30 |
| Dividend yield | 0.00% |
| Market cap | 9.13B |
| Analyst consensus | Hold (8 buy / 11 hold / 0 sell) |
| Avg price target | 132.07 USD |
Related research pages
Frequently asked questions
When is Nuvalent (NUVL)'s next earnings date?
Nuvalent is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.44 USD and revenue estimate of 0.00B.
Did NUVL beat earnings last quarter?
In its 2026-05-07 report, NUVL posted EPS of -1.39 USD versus a -1.35 USD estimate — a miss of 3%.
What is NUVL's earnings track record?
Over the last 6 reported quarters with consensus data, NUVL beat estimates 1 times (17%).
What is NUVL's current P/E ratio and EPS?
NUVL trades at a trailing P/E of -20.46 on trailing EPS of -5.721010264461572 USD.
What do analysts rate NUVL?
Analyst consensus is "Hold" across 19 ratings (0 strong buy, 8 buy, 11 hold, 0 sell, 0 strong sell). Average 12-month price target: 132.07 USD.